Details for Patent: 4,066,755

Summary for Patent: 4,066,755

Title:	Phenylaminoethanol derivatives for treating hypertension
Abstract:	Compounds of the formula: ##STR1## and physiologically acceptable acid addition salts thereof, in which R.sup.1 is A. an arylalkyl group, the alkyl portion of which contains from 1 to 6 carbon atoms and the aryl portion of which may be substituted by one or more alkoxy groups or hydroxy groups; or B. an aryloxyalkyl group, the alkyl portion of which contains from 1 to 6 carbon atoms, and the aryloxy portion of which is substituted with one or more alkoxy or hydroxy groups. These compounds have a blacking action on both .alpha.- and .beta.-adrenergic receptors and are useful in treating hypertension. Processes for the production of these compounds and pharmaceutical compositions containing them are also provided.
Inventor(s):	Lunts; Lawrence Henry Charles (London, EN), Collin; David Trevor (London, EN)
Assignee:	Allen & Hanburys Limited (London, EN)
Application Number:	05/753,558
Patent Claim Types: see list of patent claims	Use; Composition; Compound; Dosage form; Delivery;

Drugs Protected by US Patent 4,066,755

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,066,755

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	34379/69	Jul 8, 1969

International Family Members for US Patent 4,066,755

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	280996
Austria	300763
Belgium	704037